Apellis Pharmaceuticals
-$0.39 (-1.16%) Today
$0.00 (0.00%) As of 8:02 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.
About APLS
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product.
CEO
Cedric Francois
Employees
374
Headquarters
Waltham, Massachusetts
Founded
2009
APLS Key Statistics
Market Cap
2.89B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
754.70K
High Today
$34.29
Low Today
$33.09
Open Price
$33.83
Volume
564.36K
52 Week High
$73.00
52 Week Low
$27.50
Analyst Ratings
88%
of 16 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
APLS Earnings
-$2.72
-$1.50
-$0.29
$0.93
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 2, After Hours